Ludwig Lynda M, Tanaka Katsuya, Eells Janis T, Weihrauch Dorothee, Pagel Paul S, Kersten Judy R, Warltier David C
Departments of Anesthesiology, Pharmacology and Toxicology, and Medicine (Division of Cardiovascular Diseases), the Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin and the Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin.
Anesth Analg. 2004 Nov;99(5):1308-1315. doi: 10.1213/01.ANE.0000134804.09484.5D.
Reactive oxygen species (ROS) mediate volatile anesthetic preconditioning. We tested the hypothesis that isoflurane (ISO) generates ROS from electron transport chain complexes I and III. Rabbits (n = 55) underwent 30 min coronary artery occlusion followed by 3 h reperfusion and received 0.9% saline, the complex I inhibitor diphenyleneiodonium (DPI; 1.5 mg/kg bolus followed by 1.5 mg/kg over 1 h), or the complex III inhibitor myxothiazol (MYX; 0.1 mg/kg bolus followed by 0.3 mg/kg over 1 h) in the absence and presence of 1.0 minimum alveolar concentration ISO. ISO was administered for 30 min and discontinued 15 min before coronary occlusion. Infarct size and ROS production (n = 32) were determined using triphenyltetrazolium staining and ethidium-DNA fluorescence, respectively. Adenosine triphosphate (ATP) synthesis in mitochondria obtained from rabbit hearts (n = 24) subjected to drug interventions was measured by luciferin-luciferase luminometry. ISO significantly (P < 0.05) reduced infarct size (19% +/- 4%) as compared with control (39% +/- 4%). MYX (35% +/- 4%), but not DPI (24% +/- 2%), abolished this protection. ISO increased ethidium-DNA fluorescence (83 +/- 11 U) as compared with control (40 +/- 12 U). MYX (35 +/- 3 U), but not DPI (78 +/- 9 U), abolished ROS generation. DPI and MYX selectively reduced complex I- and complex III-mediated ATP synthesis, respectively. ROS generated from electron transport chain complex III mediate ISO-induced cardioprotection.
活性氧(ROS)介导挥发性麻醉药预处理。我们检验了异氟烷(ISO)从电子传递链复合物I和III产生活性氧的假说。55只兔子经历30分钟冠状动脉闭塞,随后3小时再灌注,并在不存在和存在1.0最低肺泡浓度ISO的情况下接受0.9%生理盐水、复合物I抑制剂二苯基碘鎓(DPI;1.5mg/kg静脉推注,随后1小时内1.5mg/kg)或复合物III抑制剂黏噻唑(MYX;0.1mg/kg静脉推注,随后1小时内0.3mg/kg)。ISO给药30分钟,并在冠状动脉闭塞前15分钟停药。分别使用三苯基四氮唑染色和乙锭-DNA荧光测定梗死面积和活性氧生成(n = 32)。通过荧光素-荧光素酶发光法测量接受药物干预的兔心脏(n = 24)线粒体中的三磷酸腺苷(ATP)合成。与对照组(39%±4%)相比,ISO显著(P < 0.05)减小梗死面积(19%±4%)。MYX(35%±4%)而非DPI(24%±2%)消除了这种保护作用。与对照组(40±12 U)相比,ISO增加了乙锭-DNA荧光(83±11 U)。MYX(35±3 U)而非DPI(78±9 U)消除了活性氧生成。DPI和MYX分别选择性降低复合物I和复合物III介导的ATP合成。电子传递链复合物III产生活性氧介导ISO诱导的心脏保护作用。